How obesity affects the liver's role in Alzheimer's disease

The impact of obesity-induced hepatic amyloid beta dysregulation on Alzheimer’s disease pathology

NIH-funded research Keck Graduate Inst of Applied Life Scis · NIH-10790593

This study is looking at how being overweight might affect brain health and contribute to Alzheimer's disease by examining changes in the liver, and it's designed for anyone interested in understanding the links between obesity and brain health.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionKeck Graduate Inst of Applied Life Scis NIH-funded
Lab location1 site (Claremont, United States)
Project IDNIH-10790593 on NIH RePORTER

What this research studies

This research investigates the connection between obesity and Alzheimer's disease by exploring how obesity-induced changes in the liver can influence brain health. It focuses on the liver-brain axis, particularly how fatty liver conditions may alter the levels of amyloid-beta, a protein linked to Alzheimer's pathology. The study will utilize animal models to examine the effects of a high-fat and high-sugar diet on liver function and its subsequent impact on brain amyloid levels. By understanding these mechanisms, the research aims to uncover potential pathways that could lead to new treatments for Alzheimer's disease.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals who are obese or overweight and may be at risk for developing Alzheimer's disease.

Not a fit: Patients who are not overweight or do not have a risk of Alzheimer's disease may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating Alzheimer's disease in individuals affected by obesity.

How similar studies have performed: Other research has shown promising results in understanding the relationship between obesity and Alzheimer's disease, suggesting that this approach could yield valuable insights.

Where this research is happening

Claremont, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.